Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold

Daniel D. Bu, Rocco Ferrandino, Eric M. Robinson, Shelley Liu, Brett A. Miles, Marita S. Teng, Mike Yao, Eric M. Genden, Raymond L. Chai

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Objective: To evaluate the utility of lymph node ratio (LNR) as a prognostic factor for survival and recurrence in surgically treated patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). Study Design: Retrospective cohort study. Methods: In this retrospective cohort study of a tertiary healthcare system in a major metropolitan area, we reviewed 169 consecutive patients with HPV-related OPSCC treated using transoral robotic surgery. Univariable and multivariable Cox proportional hazards regression analysis with stratified models were used to compare LNR with other traditional clinicopathologic risk factors forrecurrence and survival. An LNR cutoff was found using the minimal P approach. Results: Multivariable Cox regression models showed that each additional percentage increase in LNR corresponded to an adjusted hazard ratio (HR) of 1.04 (confidence interval [CI] 1.02–1.07). LNR was more significant when adjusted for adequate lymph node yield of ≥ 18 nodes (HR 5.05, 95% confidence interval [CI] 1.38–18.47). The minimal P generated cutoff point at LNR ≥ 17% demonstrated a HR 4.34 (95% CI 1.24–15.2) for disease-free survival. Conclusion: For HPV-related OPSCC, continuous LNR and an LNR threshold of 17% could be helpful in identifying recurrent disease in addition to measures such as lymph node number alone.

Original languageEnglish
Pages (from-to)E184-E189
JournalLaryngoscope
Volume131
Issue number1
DOIs
StatePublished - Jan 2021

Keywords

  • Lymph node ratio, lymph node yield, prognostic threshold, HPV-related oropharyngeal squamous cell carcinoma, TORS

Fingerprint

Dive into the research topics of 'Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold'. Together they form a unique fingerprint.

Cite this